Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
about
Immunomic analysis of human sarcomaA novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain proteinA simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteinsEmerging blood-based biomarkers for detection of gastric cancerGastric cancer: prevention, screening and early diagnosisAn unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactionsMolecular characterization of virus-induced autoantibody responses.Serological identification of adult T-cell leukaemia-associated antigens.Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera.Proteome-based analysis of serologically defined tumor-associated antigens in cutaneous lymphomaRebalancing immune specificity and function in cancer by T-cell receptor gene therapy.Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines.Tumor-associated autoantibody signature for the early detection of gastric cancer.Prognostic and diagnostic value of spontaneous tumor-related antibodiesAn analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumabAnti-idiotype vaccines.DNA fusion gene vaccines against cancer: from the laboratory to the clinic.DNA vaccines to attack cancerAutoantigens act as tissue-specific chemoattractants.T cell-mediated immunotherapy of metastases: state of the art in 2005.Anti-tumor antibodies in ovarian cancer.State of the art in tumor antigen and biomarker discovery.Prevalence of antitumor antibodies in laying hen model of human ovarian cancerSerum autoantibodies as biomarkers for early cancer detection.Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targeting.Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation.Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis.A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4⁺ and CD8⁺ T-cell as well as B-cell responses.Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells.
P2860
Q24554211-90288203-5E57-432D-847E-31BA7E752C73Q24648046-7B6139ED-1765-48B3-B1E6-6796E5E7A5BBQ24813048-D65CBD0E-77DF-4213-89EE-73693905F85CQ26778026-FC68D73D-62C6-451F-B3E3-0BC2298CCF73Q26860418-704FD4FA-E278-43DF-9A41-5FD419CD98AEQ28264336-366813A8-179A-4353-9B74-05B529C6AD3AQ31110185-9D0E0BC6-6335-4D66-9B96-FFDD35B7111DQ33220307-2056744F-3B90-432E-9602-1520FD212DA8Q33254440-CF8E6C1D-2114-4054-8533-2E3208356C14Q33519571-538E9AA6-88A7-4598-AC9E-7F12C79FB2B3Q34084756-CDAD22E8-248B-4B56-BD91-0E7A6AAFCAB9Q34111850-5677E1C7-C87C-43AB-B487-893C0C8C8A0DQ34299043-9C2A4A93-B451-4AA7-AC27-7F08182E4C45Q34475795-676FAB02-81BC-4FD1-A752-22302305E483Q34862104-D800C519-A2ED-44A5-8443-D7C9C1F8DD57Q35289145-4E70C87A-2B51-4EF0-803E-352D6B72C0FEQ35591089-35D45A5B-300D-4685-8134-2FE20A4F6B38Q35826392-8BF0B152-5128-4B89-AC24-A1AA9925909DQ35855143-992349FF-98A1-443A-AE6C-6A7C97855497Q36139951-777D6FA2-A4E1-4B26-BAEB-AB708C6F38D8Q36210864-C791E33D-213B-4AD3-85A5-972199178DC1Q36232263-010C784E-BB89-48F0-881E-D2ECDBE2104EQ37132800-9D489E32-82E3-45F9-88AB-669098B3C78EQ37436255-38E8126A-B2C8-485E-90AD-04804D27519FQ37622471-469C19FC-1656-4BAD-BFC5-AE244B53A509Q38085677-7B57043C-7A15-4CB8-930D-B9097E1DC531Q38300352-B758ED87-4CD6-4FA8-9929-710EC146CDCCQ39243052-DA58502E-06BF-49A7-9B7A-38329FA2D52DQ39397717-8CD05C81-57DF-4622-9803-0A74A0400266Q39424061-81614C2B-545E-4C06-8AA4-5A8CC1F77AC0Q40431375-ADA8258D-54D5-4DB8-9E0F-DFDFCC57AF14Q44781020-F58CAFA5-654E-4504-B020-46788F1DD193Q51562877-E8927B11-5A35-4EB0-A18E-380AD60EF992Q55070721-752E9DE3-F073-4AF3-81D9-7E7383EC8846
P2860
Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
@ast
Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
@en
type
label
Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
@ast
Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
@en
prefLabel
Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
@ast
Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
@en
P2093
P2860
P1476
Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
@en
P2093
Carsten Zwick
Claudia Bormann
Klaus-Dieter Preuss
P2860
P356
10.1034/J.1600-065X.2002.18805.X
P577
2002-10-01T00:00:00Z